Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is Scopus-indexed (Q4, CiteScore 0.6), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Pleiades Publishing.
Checked against the index lists dated .
ISSN 1990-7508Verify ISSN ↗1990-7516Verify ISSN ↗
Publisher: Pleiades Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Clinical Biochemistry | 117 / 124 | 6th | Q4 |
| Molecular Medicine | 172 / 179 | 4th | Q4 |
| Biochemistry | 431 / 448 | 3rd | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q4, CiteScore 0.6.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is Q4 in Clinical Biochemistry (rank 117 of 124), Q4 in Molecular Medicine (rank 172 of 179) and Q4 in Biochemistry (rank 431 of 448), by CiteScore 2025.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.6, which places it in quartile Q4 at the 6th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.158, quartile Q4, with an H-index of 18.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry is published by Pleiades Publishing. Its print ISSN is 1990-7508 and its online ISSN is 1990-7516.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry has an h-index of 21 and a 2-year mean of 0.48 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #108 of 121 Scopus journals in Clinical Biochemistry.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry published 45 papers in 2025; its busiest recent year was 2024 with 48. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from Russia (66.4%), Iraq (7.3%) and Türkiye (3.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.